News

Tirzepatide vs. Semaglutide: New Research Reveals Surprising Metabolic Differences
Researchers have discovered that tirzepatide and semaglutide impact energy metabolism in distinct ways. New animal research ...
Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...
Weight-loss medications may also benefit common medical problem, study finds
GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...
Hosted on MSN13d
‘There's a huge percentage of the US population that isn't getting access to these medications’: Novo Nordisk makes game-changing $2 billion deal for new obesity d…
The new drug in question, UBT251, is a next-generation therapy designed to tackle obesity and type 2 diabetes by ...
Eli Lilly pulls ahead of Novo in obesity drug gold rush as new players crowd in
The global weight-loss drug market, once dominated by Novo Nordisk, is undergoing a dramatic transformation. On Friday, the ...
Weight-loss drugs’ impact on cancer risk revealed in new study
Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...
BenefitsPRO3h
How obesity costs employers billions in health care and lost productivity
Employers have the opportunity to lead by example: to stop treating obesity as invisible and start addressing it as the ...
Medscape2d
Mobility Over Metrics: A New Take on Senior Obesity
Research shows intentional weight loss in older adults can lead to better mobility, reduced medical complications, and ...